A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jonathon B Cohen, MD
Emory University - Winship Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- Georgia Cancer Center at Augusta University
Augusta, Georgia, United States
- Carle Cancer Center
Urbana, Illinois, United States
- University of Kansas
Overland Park, Kansas, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Laura and Isaac Perlmutter Cancer Center at Nyu
New York, New York, United States
- University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania, United States
- University of Virginia
Charlottesville, Virginia, United States
- West Virginia University
Morgantown, West Virginia, United States
- Gundersen Health System
La Crosse, Wisconsin, United States
- University of Wisconsin
Madison, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
- Prohealth Care
Waukesha, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Aug 2018
- Primary completion
- 22 Sept 2022
- Completion
- 7 Sept 2023
- Last update posted
- 25 Jun 2026
- Registered enrollment
- 43
- Registry id
- NCT03323151
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.